Efficacy of psychological treatment for tension-type headache: a systematic review and meta-analysis Authors: Lu Yuan, Kulachai Pantila, Xin-Ying Niu, Yu-Xin Zhang, Fang Yang, Hui Zheng Published: 2025 ABSTRACT BackgroundTo assess the efficacy of psychological interventions for Tension-Type Headache (TTH) via a systematic review and meta-analysis.MethodsPubMed, Embase, Cochrane Library, and Web of Science were searched from inception to June 2025 for randomized controlled trials (RCTs) comparing psychological interventions with controls in patients with TTH. The primary outcome was the number of headache days per month, while secondary outcomes were headache intensity and the treatment response rate. The second version of the Cochrane Risk-of-Bias Tool (RoB 2.0) was used to assess the risk of bias, and GRADE was used to assess the quality of evidence.ResultsNineteen studies with 1069 participants were included. For the primary outcome, psychological interventions reduced the number of headache days per month compared to controls (5 studies, MD=-4.53, 95% CI: -5.52 to -3.54, p < 0.01, I2 = 35%), with moderate-quality evidence. For secondary outcomes, the treatment response rate was higher in the intervention group (7 studies, RR = 2.43, 95% CI: 1.32 to 4.48, p < 0.01, I²=41%). Psychological interventions also decreased headache intensity compared to controls (10 studies, MD=-1.88, 95% CI: -2.72 to -1.04, p < 0.01, I²=93%). Subgroup analysis of headache intensity indicated significant differences between interventions (P = 0.01), suggesting effect heterogeneity across psychological modalities.ConclusionsPsychological interventions effectively reduce the number of headache days, headache intensity, and improve response rates in TTH. Psychological interventions are an effective non-pharmacological approach for managing TTH, although heterogeneity in some outcomes warrants further high quality trials.Supplementary InformationThe online version contains supplementary material available at 10.1186/s10194-025-02237-3. Introduction Tension-type headache (TTH) is the most prevalent primary headache disorder worldwide [1]. It is characterized by bilateral, non-pulsatile pain of mild to moderate intensity, often described as pressing or tightening, and typically occurs without associated symptoms such as nausea, vomiting, photophobia, or phonophobia [2]. According to the Global Burden of Disease Study 2021, the estimated global prevalence of TTH reached 2.01 billion cases, surpassing that of migraine [3]. Conventional management of TTH primarily involves acute symptomatic relief with simple analgesics, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol (acetaminophen). However, prolonged reliance on these acute medications carries a risk of medication-overuse headache (MOH) [4]. For preventive treatment, tricyclic antidepressants (e.g., amitriptyline) are first-line due to demonstrated efficacy, though their use is frequently limited by anticholinergic side effects including sedation and dry mouth. Alternatives such as SNRIs (e.g., venlafaxine) offer improved tolerability and are valuable in patients with comorbid mood disorders, despite less robust evidence for headache prevention. Importantly, all pharmacotherapies require individualized selection based on tolerability and comorbidities, and should be integrated with non-pharmacological strategies to address underlying psychological contributors [5, 6]. Psychological interventions have been used in headache management; However, for tension-type headache the evidence base remains inconclusive. These encompass a range of approaches, such as: cognitive behavioral therapy (CBT), relaxation training, biofeedback, mindfulness-based stress reduction (MBSR), acceptance and commitment therapy (ACT), and stress management programs incorporating coping skills training. Collectively, they target the modulation of pain-related cognitions and emotional processing, and enhancement of sleep and behavioral patterns. CBT facilitates the identification and restructuring of maladaptive cognitive and behavioral patterns linked to pain [7]; Biofeedback promotes self-regulation through real-time monitoring of physiological signals [8]; And relaxation training and mindfulness meditation mitigate symptoms by alleviating muscle tension and regulating autonomic nervous system activity [9]. However, existing meta-analyses evaluating psychological interventions for TTH have produced inconsistent results. Lee et al. (2019) performed a subgroup analysis of seven RCTs in patients with TTH, demonstrating significant benefits for weekly headache frequency, headache index, and responder rate, but no significant improvement in the prespecified primary endpoint of monthly headache days (P = 0.24) [10]. A systematic review and meta-analysis by Krøll et al. (2021) evaluated non-pharmacological treatments for TTH, incorporating 13 RCTs. However, only three small-scale RCTs specifically examined psychological interventions, revealing no significant reduction in monthly headache frequency. The certainty of evidence was rated as very low, primarily attributable to data sparsity [11]. A recent network meta-analysis by Qin et al. (2024) ranked psychological therapy as the most effective for reducing headache intensity and indicated moderate effects on monthly headache frequency; However, this finding must be interpreted cautiously, as only three included RCTs specifically targeted psychological interventions [12]. Previous systematic reviews did not specifically evaluate the efficacy of psychological interventions for TTH and were limited by the small number of available RCTs. More recently, several rigorously conducted RCTs evaluating psychological interventions for TTH have been published [13–15]. This study provides an updated systematic review and meta-analysis to evaluate the efficacy of psychological interventions for TTH. The primary outcome was the number of headache days per month, while secondary outcomes included weekly headache frequency, headache intensity, and the proportion of patients achieving a treatment response. Methods Registration This meta-analysis was prospectively registered on the Open Science Framework (OSF) at: 10.17605/OSF.IO/HYRD2. The protocol was developed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [16]. Search strategy A comprehensive literature search was conducted in the following electronic databases: PubMed, Embase, Cochrane Library, and Web of Science, from inception to June 13, 2025. No language restrictions were applied; The detailed search strategy for pubmed is provided in supplementary eTable 1. Reference lists of included articles and relevant reviews were also manually screened to identify additional eligible trials. The search was updated prior to final analysis to include any new publications. Inclusion and exclusion criteria Study selection was conducted independently by two reviewers based on predefined inclusion and exclusion criteria. Any discrepancies were resolved through discussion or adjudication by a third reviewer. Eligible studies were randomized controlled trials (RCTs) that enrolled participants with a confirmed diagnosis of TTH according to the International Classification of Headache standard developed by the International Headache Society; Interventions included cognitive behavioral therapy, relaxation techniques (progressive muscle relaxation or autogenic training), biofeedback, mindfulness-based interventions (mindfulness-based stress reduction or mindfulness-based cognitive therapy), acceptance and commitment therapy, and stress management programs with psychological components; Comparators included placebo or usual care, or other non-psychological treatments. Primary outcome was the number of headache days per month. Secondary outcomes included headache intensity, and the treatment response rate. No restrictions were applied regarding publication type or language. Studies were excluded if they met any of the following criteria: (1) Non RCTs; (2) Included participants who had comorbid primary headache disorders (migraine or cluster headache), secondary headaches (post-traumatic or medication-overuse headache), or neurological conditions. (3) Non-psychological interventions (pharmacotherapy, acupuncture, or exercise programs); (4) Unextractable outcome data, or duplicate publications. Outcomes The primary outcome was the number of headache days per month. Secondary outcomes included headache intensity, and the treatment response rate (defined as the proportion of participants achieving at least 50% reduction in headache frequency or intensity from baseline). Data extraction Two reviewers independently extracted data from eligible studies using a standardized form in Microsoft Excel. Extracted information included: study characteristics (author, year, country, sample size), participant demographics (sex, headache duration), intervention details (type, duration, frequency), comparator details, and outcome measures. Discrepancies were resolved by discussion or consultation with a third reviewer. Risk of bias and level of evidence The risk of bias for included RCTs was assessed independently by two reviewers using the Cochrane Risk of Bias tool (RoB 2.0) [17]. Domains evaluated included randomization process, deviations from intended interventions, missing outcome data, measurement of the outcome, and selection of the reported result. Each domain was rated as low risk, some concerns, or high risk, with an overall risk of bias judgment for each study. The overall quality of evidence for the primary outcome was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach [18]. Data analysis All statistical analyses were conducted using R software, with meta-analysis performed via the meta package. Continuous outcomes (the number of headache days, headache intensity) were summarized as mean differences (MD) with 95% confidence intervals (CI), while dichotomous outcomes (the treatment response rates) were expressed as risk ratios (RR) with 95% CIs. Statistical heterogeneity was assessed with the I²statistic, with values < 30% considered low, 30–50% moderate, and >50% substantial [19]. When substantial heterogeneity was detected (I²>50%), potential sources were explored via subgroup analyses and sensitivity analyses. Subgroups were prespecified according to intervention type (relax training, biofeedback, mindfulness-based interventions). Sensitivity analyses were performed by iteratively excluding individual studies (leave-one-out method) to test the robustness of pooled estimates. Publication biases were evaluated visually using funnel plots and statistically via Egger’s regression test (applied when \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\ge\:$$\end{document}10 studies were available per outcome). Where evidence of bias was present, the trim-and-fill method was applied. Results Search results and study characteristics The database search identified 654 records, of which 45 were retrieved for full-text assessment. Nineteen studies fulfilled the predefined inclusion criteria and were included in the analysis. The study selection process is shown in Fig. 1. A total of 19 trials from 11 countries enrolled 1069 participants diagnosed with TTH. The psychological interventions investigated fell into distinct categories: (1) relaxation training, such as audio-guided relaxation and progressive muscle relaxation [14, 15, 20–24]; (2) biofeedback, primarily electromyographic biofeedback and galvanic skin response biofeedback [25–28]; (3) incorporating mindfulness-based stress reduction, rajyoga meditation, and related mental relaxation exercises [29–33]; (4) cognitive coping skills training [34]; (5) emotional release techniques [35]; and (6) short-term dynamic psychotherapy [13]. The characteristics of the included studies are shown in Table 1. Fig. 1Prisma flow chart. RCT, randomised controlled trial Prisma flow chart. RCT, randomised controlled trial Table 1Characteristics of included RCTsStudyCountrySample SizeHeadache typeInterventionOutcome measureExperimentalControlBruhn 1979Denmark13/10TTH16 times EMG biofeedbackPhysical therapy or drugsResponse rateLarsson 1990Sweden31/17TTH5-week home audio relaxationWaiting-listHeadache frequencyBlanchard 1991USA27/6TTH10 PMR sessions over 8 weeks.No interventionResponse rateLarsson 1996Sweden13/13CTTH5-week nurse administrated school relaxationNo interventionHeadache frequency,response rateRokicki 1997USA30/14CTTH6× relaxation + EMG biofeedback3 assessment-only sessionsHeadache-free days,response rateBussone 1998Italy23/12TTH10 sessions EMG BF + relaxation10 sessions relaxation placeboResponse rateLoew 2000Germany12/12CTTHDaily micro body-awareness practiceHand isotonic exerciseHeadache days,response rateHolroyd 2001USA49/48CTTHTwice cognitive copingPlacebo capsulesHeadache days,response rateSoderberg 2006Sweden30/30CTTH8 to 10 sessions of relaxation training10 Physicaltraining sessionsHeadache intensityD’Souza 2008USA34/17TTH4 × 20-min audio relaxation/written emotional disclosure4 × 20-min neutral writingHeadache days, headache intensityBembalgi 2012India74/31TTH15 × 30-min ofauditory GSR BF/visual GSR BF/audio + visual GSR BFMedicationHeadache intensity,headache frequencyBougea 2013Greece19/16FETTHEFT twice daily for 2 monthsStandard care (continue medication)Headache frequency,headache intensityCathcart 2014Australia23/19CTTHBrief mindfulness-based therapy (6 sessions over 3 weeks)No interventionHeadache daysOmidi2014Iran30/30TTHMindfulness-based stress reduction(8 weekly 120-min sessions)AntidepressantsHeadache intensityKiran2014India30/20CTTHRajyoga meditation (8 lessons + daily 20-min practice) + medicationAnalgesics + muscle relaxantsHeadache intensity, headache frequencySertel2017Turkey20/20CTTHBody awareness therapy(3 × 60 min/week, 6 weeks)No InterventionHeadache intensityGopichandran 2021India84/85CTTHProgressive muscle relaxation + deep breathing (20 min daily, 12 weeks)Standard routine careHeadache days,headache intensityShahverdi 2024Iran15/15TTHShort-term dynamic psychotherapy (16 weekly sessions)Standard medical careHeadache intensityAshibokova 2025Russia45/52CTTHAntidepressants + self-relaxationAmitriptyline 12.5–50 mg/day (or venlafaxine 75–150 mg)Headache daysUSA, United States of America; EFT, Emotional Freedom Technique; BF, biofeedback; PMR, progressive muscle relaxation; FETTH, Frequent episodic tension-type headache Table 1Characteristics of included RCTsStudyCountrySample SizeHeadache typeInterventionOutcome measureExperimentalControlBruhn 1979Denmark13/10TTH16 times EMG biofeedbackPhysical therapy or drugsResponse rateLarsson 1990Sweden31/17TTH5-week home audio relaxationWaiting-listHeadache frequencyBlanchard 1991USA27/6TTH10 PMR sessions over 8 weeks.No interventionResponse rateLarsson 1996Sweden13/13CTTH5-week nurse administrated school relaxationNo interventionHeadache frequency,response rateRokicki 1997USA30/14CTTH6× relaxation + EMG biofeedback3 assessment-only sessionsHeadache-free days,response rateBussone 1998Italy23/12TTH10 sessions EMG BF + relaxation10 sessions relaxation placeboResponse rateLoew 2000Germany12/12CTTHDaily micro body-awareness practiceHand isotonic exerciseHeadache days,response rateHolroyd 2001USA49/48CTTHTwice cognitive copingPlacebo capsulesHeadache days,response rateSoderberg 2006Sweden30/30CTTH8 to 10 sessions of relaxation training10 Physicaltraining sessionsHeadache intensityD’Souza 2008USA34/17TTH4 × 20-min audio relaxation/written emotional disclosure4 × 20-min neutral writingHeadache days, headache intensityBembalgi 2012India74/31TTH15 × 30-min ofauditory GSR BF/visual GSR BF/audio + visual GSR BFMedicationHeadache intensity,headache frequencyBougea 2013Greece19/16FETTHEFT twice daily for 2 monthsStandard care (continue medication)Headache frequency,headache intensityCathcart 2014Australia23/19CTTHBrief mindfulness-based therapy (6 sessions over 3 weeks)No interventionHeadache daysOmidi2014Iran30/30TTHMindfulness-based stress reduction(8 weekly 120-min sessions)AntidepressantsHeadache intensityKiran2014India30/20CTTHRajyoga meditation (8 lessons + daily 20-min practice) + medicationAnalgesics + muscle relaxantsHeadache intensity, headache frequencySertel2017Turkey20/20CTTHBody awareness therapy(3 × 60 min/week, 6 weeks)No InterventionHeadache intensityGopichandran 2021India84/85CTTHProgressive muscle relaxation + deep breathing (20 min daily, 12 weeks)Standard routine careHeadache days,headache intensityShahverdi 2024Iran15/15TTHShort-term dynamic psychotherapy (16 weekly sessions)Standard medical careHeadache intensityAshibokova 2025Russia45/52CTTHAntidepressants + self-relaxationAmitriptyline 12.5–50 mg/day (or venlafaxine 75–150 mg)Headache daysUSA, United States of America; EFT, Emotional Freedom Technique; BF, biofeedback; PMR, progressive muscle relaxation; FETTH, Frequent episodic tension-type headache Characteristics of included RCTs Headache frequency, response rate Headache-free days, response rate Headache days, response rate Headache days, response rate 10 Physical training sessions 15 × 30-min of auditory GSR BF /visual GSR BF /audio + visual GSR BF Headache intensity, headache frequency Headache frequency, headache intensity Omidi 2014 Mindfulness-based stress reduction (8 weekly 120-min sessions) Kiran 2014 Sertel 2017 Body awareness therapy (3 × 60 min/week, 6 weeks) Headache days, headache intensity USA, United States of America; EFT, Emotional Freedom Technique; BF, biofeedback; PMR, progressive muscle relaxation; FETTH, Frequent episodic tension-type headache Eighteen studies were evaluated as “some concerns”, and one studies were assessed as “low risk”, and the results of the Cochrane bias risk assessment are shown in eFigure 1. The GRADE evidence profile of the level of primary outcome evidence was shown in the eTable 2. The quality of the evidence was regarded as moderate due to the relatively small sample size. Primary outcome The number of headache days Five studies involving 383 participants were included in the meta-analysis evaluating the number of headache days per month. The pooled results revealed a significant reduction in monthly headache days favoring the psychological intervention group over controls (MD= -4.53, 95% CI: -5.52 to -3.54; P < 0.01, I²=35%, Fig. 2). To evaluate the robustness of the primary outcome, a leave-one-out sensitivity analysis was conducted by sequentially excluding each included study. The results were consistent, with recalculated MDs ranging from − 3.80 to -4.91 (eFigure 2). The overall effect size remained stable, suggesting that the findings are not unduly influenced by any single study. Fig. 2Forest plot of the effect of psychological interventions on monthly headache days in adults with tension‑type headache, compared with control. Footnote: The pooled estimates are represented as diamonds, and the horizontal lines represent the 95% confidence intervals. SD, standard deviation; IV, inverse variance; CI, confidence interval; df, degrees of freedom; I2, heterogeneity statistic Forest plot of the effect of psychological interventions on monthly headache days in adults with tension‑type headache, compared with control. Footnote: The pooled estimates are represented as diamonds, and the horizontal lines represent the 95% confidence intervals. SD, standard deviation; IV, inverse variance; CI, confidence interval; df, degrees of freedom; I2, heterogeneity statistic Secondary outcomes The treatment response rate Seven trials comprising 282 participants reported the treatment responder rate. Response rate was defined as participants achieving at least a 50% reduction from baseline in headache days or frequency, as specified by each trial. The pooled results showed that psychological interventions were associated with higher response rate compared to the control group (RR = 2.43, 95% CI: 1.32 to 4.48, p < 0.01, I² = 41%, Fig. 3). In the sensitivity analysis, no single study robustly affected the overall results (eFigure 3). Fig. 3Forest plot of the effect of psychological interventions on the ≥ 50% response rate in tension‑type headache, compared with control. Footnote: The pooled estimates are represented as diamonds, and the horizontal lines represent the 95% confidence intervals. MH, Mantel Haenszel; CI, confidence interval; df, degrees of freedom; I2, heterogeneity statistic Forest plot of the effect of psychological interventions on the ≥ 50% response rate in tension‑type headache, compared with control. Footnote: The pooled estimates are represented as diamonds, and the horizontal lines represent the 95% confidence intervals. MH, Mantel Haenszel; CI, confidence interval; df, degrees of freedom; I2, heterogeneity statistic The headache intensity Ten trials involving 697 participants were included in the meta-analysis evaluating the effect of psychological interventions on headache intensity. The pooled results indicated a significant reduction in headache intensity favoring the psychological intervention group over controls (MD = -1.88, 95% CI: -2.72 to -1.04; P < 0.01, I²=93%, Fig. 4). Leave-one-out sensitivity analysis demonstrated that the pooled effect was robust: exclusion of any single study did not materially alter the pooled effect (p < 0.01, eFigure 4). Assessment of publication bias through funnel plot inspection and Egger’s regression test revealed no significant asymmetry (P = 0.566, eFigure 5). Fig. 4Forest plot of the effect of psychological interventions on headache intensity in tension‑type headache, compared with control. Footnote: The pooled estimates are represented as diamonds, and the horizontal lines represent the 95% confidence intervals. SD, standard deviation; IV, inverse variance; CI, confidence interval; df, degrees of freedom; I², heterogeneity statistic Forest plot of the effect of psychological interventions on headache intensity in tension‑type headache, compared with control. Footnote: The pooled estimates are represented as diamonds, and the horizontal lines represent the 95% confidence intervals. SD, standard deviation; IV, inverse variance; CI, confidence interval; df, degrees of freedom; I², heterogeneity statistic To further investigate potential sources of heterogeneity, subgroup analyses were conducted according to the type of psychological intervention. For relaxation training, no significant reduction in headache intensity was observed compared with controls (MD =–0.60, 95%CI:–1.74 to 0.54; P = 0.31, eFigure 6). In contrast, mindfulness and meditation-based interventions demonstrated a clinically meaningful effect (MD =–2.90, 95% CI:–3.93 to–1.86; P < 0.01, eFigure 6). Similarly, the other psychological interventions, which included biofeedback, emotional freedom techniques, and short-term psychotherapy, demonstrated a significant reduction in headache intensity (MD =–2.55, 95% CI:–4.34 to–0.77; P < 0.01, eFigure 6). The test for subgroup differences was statistically significant (P = 0.01), indicating that treatment effect varied by intervention category. Specifically, mindfulness/meditation approaches produced the most consistent reductions in headache intensity, while relaxation training did not show superiority over control conditions. Subgroup analyses By intervention type, there was a significant difference between subgroups (p = 0.01; I² = 93%). Studies of mindfulness/meditation showed a greater reduction than controls (MD = − 2.90; 95% CI: −3.93 to − 1.86; p < 0.01; I² = 88%), whereas relaxation training showed no superiority over control (MD = − 0.60; 95%CI: −1.74 to 0.54; p = 0.31; I² = 88%). Studies of other psychological interventions also favoured treatment (MD = − 2.55; 95%CI: −4.34 to − 0.77; p < 0.01; I² = 93%). Subgroup analysis by headache type revealed significant better results for the treatment group than the control group in frequent episodic TTH (MD = − 3.92, 95%CI: −5.10 to − 2.74), unspecified TTH (MD = − 1.69, 95%CI: −3.13 to − 0.24; I² = 89%, P = 0.02), and CTTH (MD = − 1.67, 95%CI: −2.82 to − 0.51; I² = 95%, P < 0.01). Substantial residual heterogeneity persisted within subgroups. Analgesic consumption Post‑treatment analgesic consumption was quantifiably reported in 6 of 19 RCTs, whereas 11 trials did not report this outcome and two described qualitative reductions only. Among the six reporting trials, heterogeneity in outcome measures, and assessment windows precluded quantitative meta‑analysis. In Bruhn (1979), EMG biofeedback reduced aspirin‑equivalent drug‑units from 22 to 9 per week (p < 0.01) versus 16 to 12 in controls. In Blanchard (1991), potency‑weighted weekly medication indices decreased by approximately 30% in the relaxation arms (not statistically significant), whereas the control group showed a 15% increase. Rokicki (1997) showed tablets/week falling from 4.5 to 1.2 in relaxation/biofeedback group (p < 0.001), versus 4.4 to 3.4 in controls. In Holroyd (2001), stress‑management therapy produced a significantly greater reduction in potency‑weighted monthly analgesic pill scores at 6 months than in the placebo group (p < 0.01). Bembalgi (2012) observed non‑significant declines in the proportion using analgesics across all arms. In Sertel (2017), the body awareness therapy group had significantly lower diary‑derived analgesic‑use scores than the control arm (p < 0.05). Discussion Main findings This systematic review and meta‑analysis provides the most up‑to‑date synthesis of psychological interventions in the management of TTH. Nineteen RCTs comprising 1069 participants were included, encompassing a range of psychological approaches such as relaxation training, biofeedback, mindfulness‑based interventions, cognitive coping skills, and short‑term psychotherapy. For the primary outcome, the pooled evidence demonstrated that psychological interventions significantly reduced the number of headache days per month. Secondary outcomes further corroborated these benefits. The treatment response rate was markedly higher in intervention groups, with sensitivity analyses indicating stability. Headache intensity was also significantly diminished. Subgroup analysis by headache subtype showed that psychological interventions significantly reduced headache intensity across FETTH, unspecified/mixed TTH, and CTTH. By intervention modality, mindfulness/meditation and other psychological interventions reduced headache intensity, whereas relaxation training showed no superiority over controls. This is biologically plausible: mindfulness modulates attentional focus and the affective component of pain, reduces catastrophising, enhances body awareness and parasympathetic tone, and strengthens cognitive reappraisal/emotion regulation [36–38]. Meditation may also recruit supraspinal pain‑control circuits and endogenous opioid pathways via prefrontal, anterior cingulate, insular and limbic networks [39, 40]. These processes could lower perceived intensity without large nociceptive change, consistent with our subgroup finding. Overall, these findings underscore the therapeutic potential of psychological interventions in TTH and support their role as viable and effective non‑pharmacological treatment options. Comparison with other studies Prior meta‑analyses have largely focused on mixed headache populations rather than specifically assessing psychological interventions in TTH. Evidence derived from the few available trials has remained limited and inconsistent. A meta‑analysis by Lee et al. (2019) evaluated psychological interventions across primary headache disorders and included only seven RCTs specific to TTH. Within the TTH subgroup, psychological approaches were associated with improvements in weekly headache frequency, headache index, and responder rates; However, no significant effect was observed for monthly headache days (P = 0.24) [10]. Similarly, Krøll et al. (2021) concluded no significant impact on monthly headache frequency based on only three small RCTs, with very low evidence certainty due to sparse data [11]. In contrast, our analysis of 19 RCTs demonstrates a significant reduction in headache days. Our findings are consistent with a recent systematic review and network meta‑analysis by Qin et al. (2024), evaluating complementary and alternative medicine for TTH. In this analysis, psychological therapies were ranked highly for reducing headache intensity and moderately for decreasing headache frequency. Nevertheless, these conclusions were drawn from only three RCTs that specifically evaluated psychological interventions for TTH [12]. In contrast to these prior syntheses, our meta-analysis exclusively focused on TTH, systematically evaluating all available RCTs of psychological interventions, resulting in the inclusion of 19 trials. Covering a broad spectrum of therapeutic modalities such as relaxation training, biofeedback, cognitive‑behavioral therapy, acceptance and commitment therapy, mindfulness‑based interventions, and short‑term psychotherapy. By focusing exclusively on TTH and incorporating a larger body of evidence, our analysis yielded more precise and robust estimates of treatment efficacy. In particular, we observed stronger effect sizes for headache days, while improvements in headache intensity were also evident, albeit accompanied by substantial heterogeneity. In summary, this meta-analysis addresses inconsistencies noted in prior reviews and provides the most comprehensive evidence specific to TTH to date, thereby supporting the utility of psychological interventions as alternatives or adjuncts to pharmacological treatments. Implications for research We found considerable heterogeneity in headache intensity outcomes that persisted despite sensitivity and subgroup analyses, representing a key limitation of this meta‑analysis. This variability likely stems from differences in intervention, participant characteristics, or trial methodologies. Future research should prioritize larger sample sizes, standardized intervention protocols, and uniform outcome measures to enable more robust data pooling and minimize heterogeneity in subsequent meta-analyses. Most included studies employed short to moderate term follow-up, thereby restricting evaluation of long-term efficacy. Future trials should therefore incorporate follow-up periods of at least 6 months to better assess the durability of treatment effects, particularly in patients with chronic TTH. Analgesic consumption, another clinically relevant outcome, was underreported and heterogeneous across trials, precluding meta-analytic synthesis. Future RCTs should thus standardize endpoints for analgesic use (e.g., weekly pill counts or defined daily doses with standard deviations) and harmonize assessment windows to support comprehensive evaluation of medication reliance. Finally, future trials are needed to focus on cost-effectiveness, combination with pharmacotherapy, and telehealth delivery. These are especially critical in low-resource settings burdened by TTH. Strengths and limitations This is the first meta-analysis to specifically evaluate the efficacy of psychological interventions for TTH, incorporating recent high quality RCTs not captured in prior reviews. Several limitations warrant consideration. First, the number of trials contributing to the primary outcome was modest, and most outcomes included fewer than 10 trials, limiting precision, subgroup analyses, and assessment of publication bias. Second, considerable heterogeneity was observed for the headache intensity outcome. Neither subgroup analyses nor leave-one-out sensitivity analyses identified specific sources of this heterogeneity or meaningfully reduced it. Subgroup analysis indicated that mindfulness/meditation and other psychological interventions reduced headache intensity, whereas relaxation training did not. As this finding is exploratory, we also performed a headache‑type subgroup analysis; Psychological interventions were effective in FETTH, unspecified/mixed TTH, and CTTH, but substantial within‑subgroup heterogeneity persisted, indicating that phenotype alone does not account for the variability. We further considered other sample characteristics; However, among trials reporting headache intensity, only four trials reported disease duration, which precluded formal subgroup or meta‑regression analyses. These limitations warrant cautious interpretation of subgroup findings. Third, analgesic consumption was sparsely and heterogeneously reported across the 19 RCTs: 11 provided no post‑treatment data, two reported qualitative reductions only, and the remaining six trials used non‑commensurate measures (e.g., tablets per week, potency‑weighted indices, aspirin‑equivalent units, proportion using) at misaligned time points. Consequently, a meta‑analysis of analgesic consumption was not feasible. Finally, the follow-up periods in the included studies were generally short to moderate, limiting our ability to assess the long-term efficacy of psychological interventions for TTH. Conclusions Psychological interventions significantly reduce headache days, headache intensity in TTH. Psychological interventions represent promising alternatives or adjuncts to standard pharmacological care. Future trials are needed to clarify long‑term efficacy, evaluate psychological outcomes such as mood and quality of life, and identify the most effective psychological intervention. Supplementary information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1